Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
10/28/1991 | WO1991017257A1 MONOCLONAL ANTI-IgM ANTIBODIES, THEIR PRODUCTION AND USE, AND HYBRIDOMAS FOR PRODUCING THE SAME |
10/28/1991 | WO1991016928A1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use |
10/28/1991 | WO1991016927A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
10/28/1991 | CA2081479A1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use |
10/28/1991 | CA2081478A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
10/28/1991 | CA2079901A1 Monoclonal anti-igm antibodies, their production and use, and hybridomas for producing the same |
10/28/1991 | CA2063244A1 Fucosyl transferases involved in adhesion molecule expression |
10/27/1991 | CA2041213A1 In-vitro method for producing antigen specific human monoclonal antibodies |
10/23/1991 | EP0453097A2 Zusammensetzung enthaltend zumindest zwei verschiedene Antikörper oder deren Fragmente |
10/23/1991 | EP0453082A1 Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent |
10/23/1991 | EP0452849A1 Anti-PP4 monoclonal antibodies, method for production and use thereof |
10/23/1991 | EP0452508A1 Mouse antibody v-region gene fragment and preparation of chimera antibody by using said gene fragment |
10/23/1991 | EP0452503A1 Immunoassay of human thrombomodulin, and reagent and kit therefor |
10/23/1991 | EP0452433A1 Cytolysis inhibitor proteins (cli) and dna sequences coding for said proteins |
10/23/1991 | EP0452364A1 Method for preparing water soluble polypeptides |
10/23/1991 | EP0452319A1 Novel protein and coding sequence for detection and differentiation of siv and hiv-2 group of viruses |
10/23/1991 | EP0452315A1 Method of treating myeloid leukemias |
10/23/1991 | EP0170697B1 Toxin conjugates |
10/23/1991 | CN1055541A Improved meninggococcal polysaccharide conjugate vaccine |
10/22/1991 | US5059680 Method of isolating ca 125 antigen |
10/22/1991 | US5059654 Affinity matrices of modified polysaccharide supports |
10/22/1991 | US5059523 Cell-surface glycoproteins of human sarcomas |
10/22/1991 | US5059521 Diagnostic reagent; cancer detection; leukemia; labeling |
10/22/1991 | US5059520 Monoclonal antibody panel for blood group a antigen |
10/22/1991 | US5059419 Obtained by hyperimmunization of an equine |
10/22/1991 | CA1291294C Cationic oligopeptides having microbicidal activity |
10/21/1991 | WO1991016448A1 Human monoclonal antibody against glycoprotein gp iii of varicella zoster virus |
10/19/1991 | WO1991017187A2 A 35kD TUMOR ASSOCIATED PROTEIN ANTIGEN: USES AND METHODS OF DETECTION |
10/19/1991 | WO1991016078A1 Conjugate compounds containing aza-macrocycles, and processes for their preparation |
10/19/1991 | CA2080835A1 A 35kd tumor associated protein antigen and immune complex |
10/19/1991 | CA2058985A1 Conjugate compounds containing aza-macrocycles, and processes for their preparation |
10/19/1991 | CA2040722A1 Monoclonal antibodies against pp4, processes for the preparation thereof and the use thereof |
10/17/1991 | WO1991016348A1 Interleukin-4 binding protein-gamma |
10/17/1991 | WO1991015771A1 Combinations of hepatitis c virus (hcv) antigens for use in immunoassays for anti-hcv antibodies |
10/17/1991 | WO1991015603A1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
10/17/1991 | WO1991015586A1 Improvements relating to the detection of viruses |
10/17/1991 | WO1991015582A2 PURIFIED RAP GAPs, RAP GAP SEQUENCES, AND USES THEREOF |
10/17/1991 | WO1991015581A1 Walk-through mutagenesis |
10/17/1991 | WO1991015580A1 Gene therapy for cell proliferative diseases |
10/17/1991 | WO1991015513A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides |
10/17/1991 | WO1991015245A1 Method and composition for growing tumors from few cells |
10/17/1991 | WO1991015238A1 Methods and compositions for vaccination against hiv |
10/17/1991 | WO1991015237A1 Compositions and treatments for pneumonia in animals |
10/17/1991 | WO1991015224A1 Inhibition of disease associated with immunodeficiency virus infection |
10/17/1991 | WO1991008298A3 Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
10/17/1991 | WO1991000916A3 Receptors for fibroblast growth factors |
10/17/1991 | CA2079903A1 Gene therapy for cell proliferative diseases |
10/17/1991 | CA2079600A1 Interleukin-4 binding protein-gamma |
10/17/1991 | CA2078546A1 Methods and compositions for vaccination against hiv |
10/17/1991 | CA2040513A1 Method of diagnosing cancer |
10/16/1991 | EP0451878A1 Modifying plants by genetic engineering to combat or control insects |
10/16/1991 | EP0451763A2 Peptide derivatives with amphiphatic properties, intermediates thereof and liposomes and films comprising said derivatives |
10/16/1991 | EP0451700A1 Recombinant APP minigenes for expression in transgenic mice as models for Alzheimers's disease |
10/16/1991 | EP0451612A1 Anti-oncostatin M monoclonal antibodies |
10/16/1991 | EP0451550A2 Seroreactive epitopes of human Papillomavirus (HPV) 16 proteins |
10/16/1991 | EP0451439A1 Use of a cartilage-inducing factor (CIF) for treating hematopoietic or lymphopoietic disorders |
10/16/1991 | EP0451357A1 Pathogenesis factors of dermatophytes |
10/16/1991 | EP0434744A4 Serum immunoregulatory polypeptide and uses therefor |
10/16/1991 | EP0229810B1 Protection of proteins and the like |
10/16/1991 | EP0193561B1 Monoclonal antibodies against metal chelates |
10/15/1991 | US5057604 Novel monoclonal antibodies |
10/15/1991 | US5057598 Monoclonal antibodies reactive with endotoxin core |
10/15/1991 | US5057419 Genetically engineered plasmid and organisms for the production of specialized oils |
10/15/1991 | US5057411 For identifying specific viruses |
10/15/1991 | US5057302 Bifunctional chelating agents |
10/09/1991 | EP0450936A1 Monoclonal antibody to avermectins |
10/09/1991 | EP0450931A1 Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies |
10/09/1991 | EP0450800A1 Utilization and delivery of enzymes |
10/09/1991 | EP0450598A2 Inhibitors of the advanced glycosylation of proteins and methods of use therefor |
10/09/1991 | EP0450573A2 Antibodies for the treatment and diagnosis of Pseudomonas aeruginosa infections |
10/09/1991 | EP0450479A1 Bispecific monoclonal anti-bodies, their production and use |
10/09/1991 | EP0450472A1 Monoclonal antibodies that inhibit growth of kaposi's sarcoma |
10/09/1991 | EP0450412A1 Heat-treated IgM antibody preparations |
10/09/1991 | EP0450095A1 Method of assaying d-vanillylmandelic acid, and reagent and kit therefor |
10/09/1991 | EP0449980A1 Sequential peptide and oligonucleotide synthesis using immunoaffinity techniques |
10/09/1991 | EP0449956A1 Novel lymphokine/cytokine genes |
10/09/1991 | EP0449879A1 Heterobifunctional antibodies having specificity for platelets and thrombolytic agents |
10/08/1991 | US5055562 Fluorocarbon chain-containing antigenic conjugates |
10/08/1991 | US5055560 Useful in detection of leucine 22 antigen on T-cells fixed in formalin, zinc sulfate or Bouin's fixative |
10/08/1991 | US5055559 Anti-melanoma antibody MG-21 for diagnosis and therapy of human tumors |
10/08/1991 | US5055558 Method for the selective deproteinization of whey |
10/08/1991 | US5055557 Ultrapurification of factor IX and other vitamin K-dependent proteins |
10/08/1991 | US5055455 Inhibiting adhesion of coagulase-negative staphylococcus to a polymeric material |
10/08/1991 | US5055405 Hybridoma cell line and monoclonal antibodies to Treponema species T. denticola JD-1 and Treponema 10A |
10/08/1991 | US5055404 Monoclonal antibody specifically reactive to surface of human prostatic epithelial cells |
10/08/1991 | US5055396 Diagnostic methods and systems for quantifying apo ai |
10/08/1991 | US5055291 Compositions for preventing secondary cataracts |
10/08/1991 | US5055289 Dual specificity against therapeutically active agent and against a disease related antigen |
10/08/1991 | CA1290267C Human anti-inflammatory phospholipase inhibitor protein |
10/08/1991 | CA1290266C Monoclonal antibodies to unreduced nonenzymatically glycated proteins |
10/08/1991 | CA1290265C Monoclonal antibody specific for a pigmentation associated antigen |
10/07/1991 | CA2038978A1 Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections |
10/06/1991 | CA2039541A1 Monoclonal antibodies to avermectins |
10/04/1991 | WO1991015574A1 Purified hcv and hcv proteins and peptides |
10/04/1991 | WO1991015512A2 Hiv envelope polypeptides |
10/04/1991 | WO1991015239A1 Purified antibodies specifically directed against the lipopolysaccharides (lps) of gram negative bacteria |
10/04/1991 | CA2079804A1 Purified antibodies specifically directed against the lipopolysaccharides (lps) of gram negative bacteria |
10/04/1991 | CA2079677A1 Purified hcv and hcv proteins and peptides |
10/04/1991 | CA2078545A1 Hiv envelope polypeptides |
10/04/1991 | CA2039542A1 Inhibitors of the advanced glycosylation of proteins and methods of use therefor |